235 related articles for article (PubMed ID: 14520463)
1. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta.
Rask K; Nilsson A; Brännström M; Carlsson P; Hellberg P; Janson PO; Hedin L; Sundfeldt K
Br J Cancer; 2003 Oct; 89(7):1298-304. PubMed ID: 14520463
[TBL] [Abstract][Full Text] [Related]
2. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.
Karbova E; Davidson B; Metodiev K; Tropé CG; Nesland JM
Int J Surg Pathol; 2002 Jul; 10(3):175-80. PubMed ID: 12232570
[TBL] [Abstract][Full Text] [Related]
3. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
4. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
5. Signaling through beta-catenin and Lef/Tcf.
Novak A; Dedhar S
Cell Mol Life Sci; 1999 Oct; 56(5-6):523-37. PubMed ID: 11212302
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
Henderson BR; Galea M; Schuechner S; Leung L
J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
Chou YY; Jeng YM; Kao HL; Chen T; Mao TL; Lin MC
Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
[TBL] [Abstract][Full Text] [Related]
8. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
[TBL] [Abstract][Full Text] [Related]
9. Wnt-independent beta-catenin transactivation in tumor development.
Lu Z; Hunter T
Cell Cycle; 2004 May; 3(5):571-3. PubMed ID: 15107603
[TBL] [Abstract][Full Text] [Related]
10. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
Easwaran V; Song V; Polakis P; Byers S
J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
[TBL] [Abstract][Full Text] [Related]
13. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.
Sadot E; Conacci-Sorrell M; Zhurinsky J; Shnizer D; Lando Z; Zharhary D; Kam Z; Ben-Ze'ev A; Geiger B
J Cell Sci; 2002 Jul; 115(Pt 13):2771-80. PubMed ID: 12077367
[TBL] [Abstract][Full Text] [Related]
14. [Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary].
Wei X; Lü QJ; Sun HX; Qi YF; Wang JO; Cao CC
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):86-90. PubMed ID: 22455883
[TBL] [Abstract][Full Text] [Related]
15. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
Sharma C; Pradeep A; Wong L; Rana A; Rana B
J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
[TBL] [Abstract][Full Text] [Related]
17. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
Faleiro-Rodrigues C; Macedo-Pinto IM; Maia SS; Vieira RH; Lopes CS
Gynecol Obstet Invest; 2005; 60(2):75-83. PubMed ID: 15785075
[TBL] [Abstract][Full Text] [Related]
18. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis.
Tucker E; Buda A; Janghra B; Cpoad J; Moorghan M; Havler M; Dettmar P; Pignatelli M
Proc Nutr Soc; 2003 Feb; 62(1):229-36. PubMed ID: 12756972
[TBL] [Abstract][Full Text] [Related]
20. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
Sakanaka C; Weiss JB; Williams LT
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
